U.S. Physical Therapy (NYSE:USPH) Given New $98.00 Price Target at Barrington Research

U.S. Physical Therapy (NYSE:USPHGet Free Report) had its price target lowered by analysts at Barrington Research from $108.00 to $98.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research’s price target suggests a potential upside of 19.15% from the company’s previous close.

USPH has been the subject of a number of other reports. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday. JPMorgan Chase & Co. upped their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Finally, JMP Securities assumed coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $111.50.

Read Our Latest Stock Report on U.S. Physical Therapy

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $82.25 on Friday. The firm has a market cap of $1.24 billion, a PE ratio of 87.50, a P/E/G ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The company’s fifty day simple moving average is $88.41 and its 200-day simple moving average is $87.67. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Equities research analysts expect that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

Insider Activity

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. This trade represents a 2.46 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Creative Planning acquired a new stake in U.S. Physical Therapy during the third quarter worth about $252,000. International Assets Investment Management LLC lifted its holdings in shares of U.S. Physical Therapy by 8,414.8% during the 3rd quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock worth $195,000 after acquiring an additional 2,272 shares during the period. Cambiar Investors LLC boosted its position in shares of U.S. Physical Therapy by 31.3% during the 3rd quarter. Cambiar Investors LLC now owns 26,655 shares of the company’s stock worth $2,256,000 after acquiring an additional 6,350 shares in the last quarter. Harbor Capital Advisors Inc. increased its stake in U.S. Physical Therapy by 113.4% in the third quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company’s stock valued at $1,370,000 after acquiring an additional 8,604 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in U.S. Physical Therapy by 1.0% during the third quarter. Principal Financial Group Inc. now owns 79,817 shares of the company’s stock valued at $6,755,000 after purchasing an additional 766 shares in the last quarter.

About U.S. Physical Therapy

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.